Medications for Secondary Hyperparathyroidism
15 results
Calcitriol (calcitriol 0.25 mcg)
(Calcitriol 0.25 mcg)ATLANTIC BIOLOGICALS CORP.
Usage: Calcitriol is indicated for managing secondary hyperparathyroidism in predialysis patients with chronic renal failure, hypocalcemia in dialysis patients, and hypocalcemia due to postsurgical or idiopathic hypoparathyroidism. It enhances calcium absorption and may reduce parathyroid hormone levels and bone disease manifestations.
Calcitriol (calcitriol capsules 0.25 mcg)
(Calcitriol Capsules 0.25 mcg)Aphena Pharma Solutions - Tennessee, LLC
Usage: Calcitriol capsules are indicated for managing secondary hyperparathyroidism in predialysis patients with chronic renal failure, hypocalcemia in dialysis patients, and hypocalcemia in individuals with hypoparathyroidism, including postsurgical and idiopathic cases. It promotes calcium absorption and reduces associated metabolic bone disease effects.
Calcitriol (calcitriol)
(Calcitriol)Sun Pharmaceutical Industries, Inc.
Usage: Calcitriol is indicated for managing secondary hyperparathyroidism in predialysis patients with chronic renal failure, hypocalcemia in dialysis patients, and hypocalcemia related to postsurgical, idiopathic, or pseudohypoparathyroidism. It helps enhance calcium absorption and alleviate metabolic bone disease.
Calcitriol (calcitriol)
(Calcitriol)Aphena Pharma Solutions - Tennessee, LLC
Usage: Calcitriol capsules are indicated for managing secondary hyperparathyroidism in predialysis patients with chronic renal failure, addressing hypocalcemia and metabolic bone disease in dialysis patients, and treating hypocalcemia in individuals with postsurgical, idiopathic, or pseudohypoparathyroidism.
Calcitriol (calcitriol)
(Calcitriol)ATLANTIC BIOLOGICALS CORP.
Usage: Calcitriol is indicated for managing secondary hyperparathyroidism in predialysis patients with chronic renal failure, hypocalcemia in dialysis patients, and hypocalcemia in individuals with postsurgical, idiopathic, or pseudohypoparathyroidism. It helps improve calcium absorption and may reduce parathyroid hormone levels and related bone complications.
Cinacalcet (cinacalcet)
(Cinacalcet)AvPAK
Usage: Cinacalcet tablets are indicated for treating secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, hypercalcemia in patients with parathyroid carcinoma, and hypercalcemia in adults with primary hyperparathyroidism who cannot undergo parathyroidectomy. It is not recommended for patients with CKD not on dialysis due to hypocalcemia risk.
Doxercalciferol (doxercalciferol)
(Doxercalciferol)Hikma Pharmaceuticals USA Inc.
Usage: Doxercalciferol injection is indicated for treating secondary hyperparathyroidism in patients with chronic kidney disease who are undergoing dialysis.
Doxercalciferol (doxercalciferol)
(Doxercalciferol)Meitheal Pharmaceuticals Inc.
Usage: Doxercalciferol Injection is indicated for treating secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) who are on dialysis.
Doxercalciferol (doxercalciferol)
(Doxercalciferol)Alembic Pharmaceuticals Inc.
Usage: Doxercalciferol Injection is indicated for treating secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) who are on dialysis.
Doxercalciferol (doxercalciferol)
(Doxercalciferol)Amneal Pharmaceuticals LLC
Usage: Doxercalciferol injection is indicated for treating secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) who are undergoing dialysis.